4
Changes in Ownership
BioAge Labs, Inc. Filed Acc 0001210905-25-000004
Chief Medical Officer sold 68,897 shares at $10.19 ($701,909)
- Chief Medical Officer acquired 68,897 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
RUBIN PAUL D · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-04 | Exercise or conversion : show line 1 in the form 10b5-1 | +68,897 | $4.11 | $283,167 | 68,897 | D |
| 2025-12-04 | Sale : show line 2 in the form 10b5-1 | −68,897 | $10.19 | $701,909 | 0 | D |
| Open-market sales · 68,897 sh · avg $10.19 · $701,909 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-04 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −68,897 | 21,736 | D |
Loading xslF345X05/form4-12052025_111241.xml…